These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7031186)

  • 1. Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage.
    Chowdhary UM; Sayed K
    J Neurol Neurosurg Psychiatry; 1981 Sep; 44(9):810-3. PubMed ID: 7031186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid.
    Chowdhary UM; Carey PC; Hussein MM
    Lancet; 1979 Apr; 1(8119):741-3. PubMed ID: 85988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.
    Gelmers HJ
    Acta Neurochir (Wien); 1980; 52(1-2):45-50. PubMed ID: 7376944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
    Adams HP; Nibbelink DW; Torner JC; Sahs AL
    Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
    Shucart WA; Hussain SK; Cooper PR
    J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. epsilon-aminocaproic acid in prevention of subarachnoid haemorrhage.
    Wintzen AR; Van Rossum J
    Lancet; 1979 May; 1(8125):1084. PubMed ID: 86803
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.
    Ameen AA; Illingworth R
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):220-6. PubMed ID: 7229645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.
    Fodstad H; Forssell A; Liliequist B; Schannong M
    Neurosurgery; 1981 Feb; 8(2):158-65. PubMed ID: 7010203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review.
    Galassi G; Gibertoni M; Corradini L; Colombo A
    Ital J Neurol Sci; 1983 Dec; 4(4):489-92. PubMed ID: 6674249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report.
    Brodkin HM
    J Neurosurg; 1980 Nov; 53(5):690-2. PubMed ID: 7431078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of frusemide and epsilon-amino-caproic-acid in transurethral prostatectomy. a review after 7 years.
    Smart CJ
    Br J Urol; 1982 Aug; 54(4):437. PubMed ID: 7116117
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
    van Rossum J; Wintzen AR; Endtz LJ; Schoen JH; de Jonge H
    Ann Neurol; 1977 Sep; 2(3):238-42. PubMed ID: 365072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: E-aminocaproic acid and subarachnoid haemorrhage.
    Uttley D; Richardson AE
    Lancet; 1974 Nov; 2(7888):1080-1. PubMed ID: 4138295
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
    Alvarez Garijo JA; Vilches JJ; Aznar JA
    J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
    Fodstad H
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of bleeding after renal biopsy with epsilon-amino-caproic acid.
    Savdie E; Mahony JF; Storey BG
    Br J Urol; 1978 Feb; 50(1):8-11. PubMed ID: 630206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report.
    Tubbs RR; Benjamin SP; Dohn DE
    J Neurosurg; 1979 Jul; 51(1):94-7. PubMed ID: 448423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.